BioCanRx HQP Travel Award - NOW OPEN
Summary
The BioCanRx mission is to build and foster a network that accelerates Canada’s most promising biologically based cancer therapies into clinical trials. Canadian scientists and students involved in the research and development of cancer biotherapeutics are central to achieving our mission, and we believe that staying current with the field and continually updating one’s skill sets are important to your personal success, the network and the entire field. Below is a travel award opportunity for HQP.
The third CellCAN pan-Canadian Strategic Forum is taking place in Ottawa from September 19 to 21, 2022.
In partnership with the C3i Center and CCRM, this Strategic Forum represents a great opportunity to identify concrete actions - from manufacturing to commercialization - that can be taken to help stakeholders in our field become better equipped to develop cell, tissue and gene therapies.
Bringing together national and international experts, this forum will:
- Feature how the pandemic biotherapeutic response elements have redefined the CGT and advanced therapies landscape;
- Discuss novel initiatives to increase biomanufacturing capacity, including government programs, public private partnerships and other;
- Delineate how recent investments leverage further investment opportunities and the impact to the CGT ecosystem;
- Discover the key solutions to overcoming the talent shortage to build the required skilled workforce;
- Discuss the impact of regulatory reform creating favorable and globally competitive regulation and reimbursement schema and trends for novel CGT therapeutics;
- Highlight paths to financing and reimbursement that pave the way for market access;
- Identify effective commercialization strategies for the benefit of all Canadians;
- Be a great opportunity for networking.
Eligibility
To be eligible for this award, you must not have received BioCanRx travel award funding in this calendar year; priority will be given to HQP who have not received previous travel awards.
HQP are defined as anyone working in the cell and gene therapy space inclusive of undergraduate and graduate students, post-doctoral fellows, and research, clinical and manufacturing staff. This award opportunity is open to all HQP fitting the above criteria; however priority will be given to BioCanRx HQP defined as working with BioCanRx Network Investigators (defined currently or previously receiving research funding.)
If you are unsure about your eligibility, please contact Sarah Ivanco, Manager of EDI and Training Programs, at sivanco@biocanrx.com.
Program Deliverables
The goal of BioCanRx HQP* Travel Awards and Lab Exchanges is to enable professional and technical development for the benefit of the HQP and for the network at-large. The awards will provide funding to support HQP access to external opportunities not offered by the network. Please see the criteria below to determine the appropriate opportunity for you!
The timeline for HQP Travel Awards are as follows:
- July 22, 2022 (at 11:59PM EST) – Travel Award Application Deadline
- September 19-21, 2022 – Event Dates
Specific Terms of the Award
BioCanRx will provide up to two awards to HQP. Eligible expenses that can be reimbursed include travel fare, accommodation and meals (excluding alcohol) not provided at the event. Each award will offer up to $1,200 CAD in reimbursement. Please note that BioCanRx cannot reimburse event registration costs. More information about our travel policy will be sent out to successful awardees. The value of the award is reimbursed directly to the awardee following the event.
Awardees must complete a post-event report/feedback form in order to be reimbursed by BioCanRx.
Application Procedure
Download and fill out the application form with the required documentation and send your application package to sivanco@biocanrx.com by the deadline July 22, 2022.